Search

everythinglearnresearchcommunity

for

Search:↓

Tiny particles from umbilical cord stem cells may help hair grow back in a type of hair loss.

Alopecia areata may be linked to kidney issues, but more research is needed.

Early treatment and multidisciplinary care are key to managing Frontal Fibrosing Alopecia and preventing further hair loss.

Alopecia areata causes hair loss and has various treatment options, but responses differ.

A rare hair regrowth pattern can occur in some people with alopecia areata.

Ayurvedic treatment successfully regrew hair in a 7-year-old girl with alopecia areata.

An 11-year-old girl's hair regrew after treating her thyroid condition with carbimazole.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Alopecia areata causes sudden hair loss, often on the scalp, and can be severe, especially with early onset or related health issues.

Some people with alopecia areata, a hair loss condition, get better within a year without treatment, but it can happen again.

Homoeopathic treatment may help restore hair in Alopecia Areata by balancing the immune system.

People with alopecia areata have different blood markers that suggest inflammation and immune system issues compared to healthy individuals.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

JAK inhibitors help treat alopecia areata but have high recurrence after stopping.

New treatments for child hair loss due to immune issues are effective but not yet officially approved.

The skin's bacteria might influence the development of a hair loss condition called alopecia areata.

Human Beta Defensin 1 levels do not predict the risk or severity of Alopecia Areata.

Screening for iron levels in patients with hair loss may help find a genetic iron overload condition early.

Steroid injections are more effective than platelet rich plasma for treating patchy hair loss.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

Alopecia causes patchy hair loss and can be diagnosed with new techniques; treatments like strong creams and contact immunotherapy can help.